LI
IART icon

Leeward Investments’s Integra LifeSciences IART Stock Holding History

Leeward Investments’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.29M Sell
350,152
-5,399
-2% -$75.5K 0.29% 128
2026
Q1 		$3.35M Sell
355,551
-9,481
-3% -$104K 0.17% 138
2025
Q4 		$4.53M Sell
365,032
-1,883
-0.5% -$25K 0.23% 139
2025
Q3 		$5.26M Sell
366,915
-7,894
-2% -$108K 0.27% 138
2025
Q2 		$4.6M Sell
374,809
-13,939
-4% -$202K 0.24% 138
2025
Q1 		$8.55M Sell
388,748
-16,758
-4% -$394K 0.45% 102
2024
Q4 		$9.2M Buy
405,506
+29,402
+8% +$642K 0.46% 97
2024
Q3 		$6.83M Sell
376,104
-224,104
-37% -$5.19M 0.32% 131
2024
Q2 		$17.5M Buy
600,208
+147,770
+33% +$4.38M 0.8% 39
2024
Q1 		$16M Buy
452,438
+68,247
+18% +$2.73M 0.71% 51
2023
Q4 		$16.7M Sell
384,191
-3,017
-0.8% -$119K 0.79% 43
2023
Q3 		$14.8M Sell
387,208
-29,576
-7% -$1.24M 0.76% 50
2023
Q2 		$17.1M Buy
416,784
+66,380
+19% +$3.19M 0.8% 38
2023
Q1 		$20.1M Sell
350,404
-17,406
-5% -$981K 0.92% 29
2022
Q4 		$20.6M Sell
367,810
-2,015
-0.5% -$103K 0.91% 32
2022
Q3 		$15.7M Buy
369,825
+93,417
+34% +$4.79M 0.75% 49
2022
Q2 		$14.9M Buy
276,408
+51,094
+23% +$3.07M 0.68% 56
2022
Q1 		$14.5M Buy
+225,314
New +$14.8M 0.57% 77

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Leeward Investments's IART Position: Q2 2026 in Review

Leeward Investments reduced its Integra LifeSciences (IART) stake by 1.5% in Q2 2026, selling an estimated $75.5K and leaving 350,152 shares worth $6.29M. The position accounts for 0.29% of the portfolio, ranked #128.

Leeward Investments first reported a position in IART in Q1 2022 and has held it in 18 quarters since. The position peaked at $20.6M in Q4 2022. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Leeward Investments held 350,152 shares of Integra LifeSciences worth $6.29M as of Q2 2026.
  • Leeward Investments sold 5,399 Integra LifeSciences shares in Q2 2026, an estimated $75.5K.
  • Integra LifeSciences made up 0.29% of Leeward Investments's portfolio in Q2 2026, its #128 holding.
  • Leeward Investments first reported a position in Integra LifeSciences in Q1 2022 and has held it in 18 quarters since.
  • Leeward Investments's Integra LifeSciences position peaked at $20.6M in Q4 2022.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Leeward Investments's 13F filing for Q2 2026, filed 30 Jul 2026.